Investing

BridgeBio Oncology Therapeutics, Inc. : BBOT

BBOT

Stock Data

$8.39

$0.02 (0.24%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

BridgeBio Oncology Therapeutics, Inc. is an innovative clinical-stage biopharmaceutical company based in South San Francisco, California, focused on developing targeted small molecule inhibitors for various cancer indications. The company utilizes a comprehensive drug discovery platform to create precision medicine solutions aimed at addressing significant unmet medical needs in oncology. With a diverse pipeline of therapeutics at multiple development stages, BridgeBio is strategically dedicated to identifying and targeting specific genetic drivers of cancer, enhancing treatment efficacy, and ultimately improving patient outcomes in the competitive oncology market.

All BBOT Articles

1 Article

Lee Jackson | Feb 11, 2026 at 7:50 AM EST

Here Are Wednesday’s Top Wall Street Analyst Research Calls: BP Plc., Cloudflare, Dick’s Sporting Goods, Mattel, Noble Corp., Qualcomm, Tyler Technologies, XPO, and More

Pre-Market Stock Futures: Futures are trading higher after a stellar and surprising January jobs report as we get to the…